Alector, Inc. (NASDAQ: ALEC) Stock Information | RedChip

Alector, Inc. (NASDAQ: ALEC)


$2.2500
-0.2700 ( -4.26% ) 1.9M

Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.

Market Data


Open


$2.2500

Previous close


$2.5200

Volume


1.9M

Market cap


$231.13M

Day range


$2.2250 - $2.5200

52 week range


$2.2250 - $8.9000

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 04, 2024
4 Insider transactions 1 Jun 04, 2024
4 Insider transactions 1 Jun 04, 2024
4 Insider transactions 1 May 31, 2024
8-k 8K-related 13 May 08, 2024
10-q Quarterly Reports 48 May 08, 2024
4 Insider transactions 1 May 02, 2024
ars Annual reports 1 Apr 25, 2024
def Proxies and info statements 16 Apr 25, 2024
4 Insider transactions 1 Mar 21, 2024

Latest News